← All chemicals

CAS 62-53-3

Aniline

carcinogenHAPOSHA carcinogenmethemoglobin former

Aniline is the chemical precursor to MDI isocyanate, which makes polyurethane foam in almost everything — from mattresses to car seats. It is the same class of compound as nitrobenzene in its ability to cause methemoglobinemia, and workers in dye and rubber manufacturing have been studied for bladder cancer, though IARC rates the human evidence for aniline itself as inadequate.

Where It Comes From

Aniline was first isolated from coal tar in 1826 and became one of the most important industrial chemicals of the 19th century as a dye precursor — aniline dyes launched the synthetic textile dye industry [1]. Today the majority of aniline production goes to methylene diphenyl diisocyanate (MDI) for polyurethane production, with smaller amounts used in rubber additives, agricultural chemicals, and pharmaceuticals. About 7 billion pounds are produced annually globally [2]. Production facilities are concentrated in the Gulf Coast region. Aniline contamination of soil and groundwater occurs near manufacturing facilities and from historical waste disposal. Aniline can also be formed from environmental reduction of nitrobenzene in anaerobic conditions [3].

How You Are Exposed

Occupational inhalation and skin absorption in aniline manufacturing, rubber processing, and dye manufacturing are the primary routes [1]. Aniline is readily absorbed through both inhalation and skin contact — a spill on skin can cause significant systemic toxicity. Community air near production facilities and nitrobenzene reduction in contaminated groundwater are environmental sources [2]. Consumer exposure from products made with aniline-derived chemicals is generally very low once the final polymers or dyes are formed [3]. IARC notes that tobacco smoke is thought to be the main source of exposure in the general population, that aniline has been found in drinking water near contaminated sites, and that it can occur in tattoo and pen inks [5].

Why It Matters

Aniline, like nitrobenzene, causes methemoglobinemia by oxidizing hemoglobin iron — producing cyanosis, weakness, and at high levels, cardiovascular collapse [1]. Bladder cancer is the primary long-term carcinogenic concern — aniline is metabolized to reactive ortho-aminophenols and hydroxylaminobenzene that accumulate in urine and react with bladder urothelium. The dye industry's bladder cancer epidemic of the early 20th century (sometimes called "aniline cancer") established that some aromatic amines, such as benzidine and 2-naphthylamine, cause bladder cancer. For aniline itself, bladder cancer in rubber-chemical plants has been attributed mainly to o-toluidine, and IARC rates the human evidence as inadequate [5]. Since 2020 IARC has classified aniline as Group 2A, probably carcinogenic to humans: there is sufficient evidence in experimental animals, human evidence is inadequate, and the grade rests on strong evidence that aniline behaves like aromatic amines already known to cause cancer (o-toluidine, 2-naphthylamine, 4-aminobiphenyl). Occupational exposure is therefore treated with caution [5].

Who Is at Risk

Workers in aniline production, MDI/polyurethane manufacturing, rubber processing, and dye manufacturing face occupational exposures [1]. People who had significant exposure to aromatic amines in dye manufacturing historically (especially those employed in the mid-20th century before modern controls) should be aware of elevated bladder cancer risk and discuss screening with their physician [2].

How to Lower Your Exposure

Workers in aniline environments: use enclosed systems and local exhaust ventilation; wear impermeable nitrile or neoprene gloves and chemical splash protection [1]. Regular urinalysis and urine cytology (checking for abnormal bladder cells) should be part of health monitoring for workers with significant aniline exposure history [2]. Community members near aniline production facilities should consult EPA's ECHO and Envirofacts databases for facility emission profiles [3].

References

  1. [1]ATSDR. Aniline: Medical Management Guidelines (last reviewed 2014). https://wwwn.cdc.gov/TSP/ToxFAQs/ToxFAQsDetails.aspx?faqid=448&toxid=79
  2. [2]EPA. Aniline. https://www.epa.gov/sites/default/files/2016-09/documents/aniline.pdf
  3. [3]Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control. 1997;8(3):346-55.
  4. [4]NIOSH. Aniline. https://www.cdc.gov/niosh/npg/npgd0027.html
  5. [5]IARC. Monographs Vol 127: Some aromatic amines and related compounds, Q&A (2020). https://www.iarc.who.int/featured-news/iarc-monographs-evaluation-of-the-carcinogenicity-of-some-aromatic-amines-and-related-compounds

Recovery & Clinical Information

Body Half-Life

Aniline is rapidly absorbed and metabolized — blood half-life is approximately 3-7 hours [1]. It causes methemoglobinemia via oxidation of hemoglobin; para-aminophenol is a urinary metabolite [2].

Testing & Biomarkers

Methemoglobin percentage on co-oximetry for acute toxicity [1]. Urinary para-aminophenol for occupational monitoring [2].

Interventions

Methylene blue (1-2 mg/kg IV) for significant methemoglobinemia; remove from source [1]. Occupational: PPE, engineering controls, biological monitoring program in dye/rubber manufacturing [2].

Recovery Timeline

Methemoglobin normalizes within 1-2 hours with methylene blue treatment [1]. Hemolytic anemia from aniline exposure recovers over 1-3 weeks [2].

Recovery References

  1. [1]ATSDR. Aniline: Medical Management Guidelines (last reviewed 2014). https://wwwn.cdc.gov/TSP/ToxFAQs/ToxFAQsDetails.aspx?faqid=448&toxid=79
  2. [2]EPA IRIS (1988). Aniline IRIS. https://iris.epa.gov/ChemicalLanding/&substance_nmbr=350

Track your exposure to Aniline

PollutionProfile maps your lifetime exposure history to EPA-tracked chemicals.

Get early access

We use cookies and analytics to understand how people use PollutionProfile and improve the experience. We never sell your data. Learn more.